Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1960 1
1967 1
1969 3
1970 3
1980 3
1981 8
1982 13
1983 11
1984 11
1985 14
1986 23
1987 23
1988 25
1989 30
1990 37
1991 44
1992 54
1993 73
1994 81
1995 79
1996 101
1997 123
1998 121
1999 134
2000 149
2001 175
2002 225
2003 250
2004 274
2005 391
2006 498
2007 574
2008 662
2009 740
2010 807
2011 1088
2012 1185
2013 1365
2014 1494
2015 1591
2016 1642
2017 1856
2018 2129
2019 2464
2020 2694
2021 3189
2022 3750
2023 3657
2024 4091
2025 3564
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37,202 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. Among authors: lu j. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
Bi Y, Li M, Liu Y, Li T, Lu J, Duan P, Xu F, Dong Q, Wang A, Wang T, Zheng R, Chen Y, Xu M, Wang X, Zhang X, Niu Y, Kang Z, Lu C, Wang J, Qiu X, Wang A, Wu S, Niu J, Wang J, Zhao Z, Pan H, Yang X, Niu X, Pang S, Zhang X, Dai Y, Wan Q, Chen S, Zheng Q, Dai S, Deng J, Liu L, Wang G, Zhu H, Tang W, Liu H, Guo Z, Ning G, He J, Xu Y, Wang W; BPROAD Research Group. Bi Y, et al. Among authors: lu j. N Engl J Med. 2025 Mar 27;392(12):1155-1167. doi: 10.1056/NEJMoa2412006. Epub 2024 Nov 16. N Engl J Med. 2025. PMID: 39555827 Clinical Trial.
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
Liu J, Li Y, Ge J, Yan X, Zhang H, Zheng X, Lu J, Li X, Gao Y, Lei L, Liu J, Li J; ESPRIT Collaborative Group. Liu J, et al. Among authors: lu j. Lancet. 2024 Jul 20;404(10449):245-255. doi: 10.1016/S0140-6736(24)01028-6. Epub 2024 Jun 27. Lancet. 2024. PMID: 38945140 Clinical Trial.
Prevalence of diabetes among men and women in China.
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National Diabetes and Metabolic Disorders Study Group. Yang W, et al. Among authors: lu j. N Engl J Med. 2010 Mar 25;362(12):1090-101. doi: 10.1056/NEJMoa0908292. N Engl J Med. 2010. PMID: 20335585 Free article.
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
Xu L, Su X, He Z, Zhang C, Lu J, Zhang G, Sun Y, Du X, Chi P, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Z, Zheng M, Xiao Y; RELARC Study Group. Xu L, et al. Among authors: lu j. Lancet Oncol. 2021 Mar;22(3):391-401. doi: 10.1016/S1470-2045(20)30685-9. Epub 2021 Feb 12. Lancet Oncol. 2021. PMID: 33587893 Clinical Trial.
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial.
Han B, Feinstein T, Shi Y, Chen G, Yao Y, Hu C, Shi J, Feng J, Wu H, Cheng Y, Guo QS, Jie Z, Ye F, Zhang Y, Liu Z, Mao W, Zhang L, Lu J, Zhao J, Bazhenova L, Ruiz J, Kloecker GH, Sujith KR, Oliff IA, Wong M, Liu B, Wu Y, Huang L, Sun Y; DUBLIN-3 study group. Han B, et al. Among authors: lu j. Lancet Respir Med. 2024 Oct;12(10):775-786. doi: 10.1016/S2213-2600(24)00178-4. Epub 2024 Sep 9. Lancet Respir Med. 2024. PMID: 39265599 Clinical Trial.
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy.
Aleman A, Van Oekelen O, Melnekoff DT, Grossman L, Mouhieddine TH, Kurowski A, Odak I, Reci S, Desai S, Meledathu S, Naidu MP, Shukla RP, Dutta RP, Kappes K, Serebryakova K, Jackson H, Lu J, Chatikhine A, Kulkarni R, Moinfar Z, Croken MM, Mehrotra M, Baskovich B, Rayamajhi S, Richard S, Rossi AC, Salib C, Houldsworth J, Brown BD, Merad M, Laganà A, Brunner PM, Jagannath S, Brody JD, Parekh S. Aleman A, et al. Among authors: lu j. N Engl J Med. 2025 Aug 21;393(8):823-825. doi: 10.1056/NEJMc2504588. N Engl J Med. 2025. PMID: 40834307 Free PMC article. No abstract available.
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial.
Wang X, Zhang Y, Wang H, Wu X, He C, Lin S, Pang K, Li Y, Chen Y, Tang X, Liu X, Wang J, Ye S, Yan R, Guan T, Dai B, Lu J, He H, Lin L, Lu H, Li T, Zhou L, Ye L, Zhao J, Liu Y, Ta N, Wu J, Cai W, Wan Z, Zhang S, Sun R, Zhao X, Wang J, Lin Y, Ning B, Zhao Z, Tang X, Du J, Mao Z, He Y, Zheng H, Sun L, Lin X, Xu H. Wang X, et al. Among authors: lu j. Nat Med. 2025 Aug 27. doi: 10.1038/s41591-025-03899-x. Online ahead of print. Nat Med. 2025. PMID: 40866583
37,202 results
You have reached the last available page of results. Please see the User Guide for more information.